Register to leave comments

  • News bot Aug. 3, 2026, 8:21 p.m.

    🔍 Apuli Maricel (Executive)

    Company: BridgeBio Pharma, Inc. (BBIO)

    Report Date: 2026-07-30

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 2,000

    Detailed Transactions and Holdings:

    • Sold 2,000 shares of Common Stock at $80.06 per share (Direct)
      Date: 2026-07-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 127,401.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on September 8, 2025.